Author: Craig Boerner
Doxycycline ineffective at shrinking aortic aneurysms in two-year study
May. 26, 2020—Common antibiotic doxycycline reduces inflammation without changing aneurysm growth
Vanderbilt investigators encouraged by early results of placebo-controlled remdesivir trial
Apr. 29, 2020—A preliminary look at data from hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) in a randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir is showing promising results.
Urologist Dmochowski named ABU president
Apr. 23, 2020—The American Board of Urology (ABU) is naming Roger Dmochowski, MD, MMHC, professor, Department of Urologic Surgery, and associate surgeon-in-chief at Vanderbilt University Medical Center, as its president for 2020-2021.
Study launched to test hydroxychloroquine as treatment for COVID-19
Apr. 8, 2020— by Craig Boerner Faced with a global pandemic of a virus previously unknown to humans, Vanderbilt University Medical Center (VUMC) is leading a clinical trial to understand if hydroxychloroquine, a well-known drug used for malaria and rheumatologic conditions, is safe and effective in treating hospitalized adults with COVID-19. The ORCHID trial (Outcomes Related to...
Study examines prostate cancer treatment decisions
Jan. 23, 2020—A five-year follow-up study of more than 2,000 U.S. men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care.
The American College of Medical Genetics and Genomics advises evaluating all breast cancer patients to determine the need for genetic testing
Dec. 13, 2019—According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.
All-in-one pill helps reduce blood pressure, cholesterol
Sep. 19, 2019—A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study.
VUMC receives grant for opioid education training
Aug. 29, 2019—The AAMC Opioid Education Challenge Grant Program has selected five institutions or partnering institutions to receive an award of up to $25,000 each for opioid education training.
Study drug delays type 1 diabetes in high risk children and adults
Jun. 9, 2019—Drug delays onset of type 1 diabetes by two years
Dmochowski Receives AUA’s Victor A. Politano Award
Jun. 7, 2019—VUMC's Dmochowski Receives AUA’s Victor A. Politano Award
VUMC, UCSF win KidneyX award for home dialysis design
May. 3, 2019—A roadmap to create an implantable dialysis system that would allow patients to treat kidney failure at home has won researchers from Vanderbilt University Medical Center (VUMC), UC San Francisco (UCSF), and Silicon Kidney one of 15 cash prizes in the inaugural KidneyX’s Redesign Dialysis Phase I competition.
Society of Urologic Oncology honors Smith’s contributions
Apr. 4, 2019—Joseph “Jay” Smith Jr., MD, professor of Urologic Surgery, has been awarded the 2019 Willet F. Whitmore Jr. Award and Lectureship from the Society of Urologic Oncology (SUO).
